• Clinical Evidence

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

Image
Setting: Atrium Health Wake Forest Baptist Intensive Care Units

Objective

To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.

Setting

Atrium Health Wake Forest Baptist Intensive Care Units

Results

  • Significant Patient Population: The study analyzed data from 354 patients on the Endotool IV dashboard, with 53.3% treated using EndoTool IV and 46.6% receiving standard treatment.
  • Reduced Length of Stay: Patients treated with EndoTool IV had a shorter hospital stay (3.95 days) compared to those with standard insulin infusion (4.40 days), resulting in a cost difference of $12,000,000 between the two groups.
  • Enhanced Safety: EndoTool IV demonstrated lower number of hypoglycemia and severe hypoglycemia events, ensuring safer management of glucose levels compared to standard insulin infusion.

Conclusions

  • Reduced Length of Stay: Patients treated with EndoTool IV experience shorter hospital stays, allowing for quicker recovery and increased bed availability.
  • Enhanced Patient Safety: EndoTool IV minimizes hypoglycemia and severe hypoglycemia events through a gentler approach to achieving glycemic targets, ensuring safer insulin titration.
  • Significant Cost Savings: By reducing hospital length of stay and lowering hypoglycemia events, EndoTool IV delivers substantial cost savings for healthcare systems.
Objective

To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.

Setting

Atrium Health Wake Forest Baptist Intensive Care Units

Results
  • Significant Patient Population: The study analyzed data from 354 patients on the Endotool IV dashboard, with 53.3% treated using EndoTool IV and 46.6% receiving standard treatment.
  • Reduced Length of Stay: Patients treated with EndoTool IV had a shorter hospital stay (3.95 days) compared to those with standard insulin infusion (4.40 days), resulting in a cost difference of $12,000,000 between the two groups.
  • Enhanced Safety: EndoTool IV demonstrated lower number of hypoglycemia and severe hypoglycemia events, ensuring safer management of glucose levels compared to standard insulin infusion.
Conclusions
  • Reduced Length of Stay: Patients treated with EndoTool IV experience shorter hospital stays, allowing for quicker recovery and increased bed availability.
  • Enhanced Patient Safety: EndoTool IV minimizes hypoglycemia and severe hypoglycemia events through a gentler approach to achieving glycemic targets, ensuring safer insulin titration.
  • Significant Cost Savings: By reducing hospital length of stay and lowering hypoglycemia events, EndoTool IV delivers substantial cost savings for healthcare systems.

References

Authors

M. McKnight, C. Price, C. Usoh, G.Russell, R. Bundy, J. Aloi

Source

American Association of Clinical Endocrinology (AACE) Annual Meeting

Year

2024

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.

Setting

Atrium Health Wake Forest Baptist Intensive Care Units

Results
  • Significant Patient Population: The study analyzed data from 354 patients on the Endotool IV dashboard, with 53.3% treated using EndoTool IV and 46.6% receiving standard treatment.
  • Reduced Length of Stay: Patients treated with EndoTool IV had a shorter hospital stay (3.95 days) compared to those with standard insulin infusion (4.40 days), resulting in a cost difference of $12,000,000 between the two groups.
  • Enhanced Safety: EndoTool IV demonstrated lower number of hypoglycemia and severe hypoglycemia events, ensuring safer management of glucose levels compared to standard insulin infusion.
Conclusions
  • Reduced Length of Stay: Patients treated with EndoTool IV experience shorter hospital stays, allowing for quicker recovery and increased bed availability.
  • Enhanced Patient Safety: EndoTool IV minimizes hypoglycemia and severe hypoglycemia events through a gentler approach to achieving glycemic targets, ensuring safer insulin titration.
  • Significant Cost Savings: By reducing hospital length of stay and lowering hypoglycemia events, EndoTool IV delivers substantial cost savings for healthcare systems.

References

Authors

M. McKnight, C. Price, C. Usoh, G.Russell, R. Bundy, J. Aloi

Source

American Association of Clinical Endocrinology (AACE) Annual Meeting

Year

2024

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

How Corewell Health Reduced LOS for DKA Patients, Slashing Costs by Almost $1M

How Corewell Health Reduced LOS for DKA Patients, Slashing Costs by Almost $1M

The objective of this study was to evaluate the impact of EndoTool IV insulin dosing software on mortality, length of stay, readmission rates, and cost of care for patients treated for Diabetic Ketoacidosis (DKA) at Corewell Health West.
Image
  • Clinical Evidence

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Image
  • Clinical Evidence

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

20 minute read

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.